Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Page 2 of 8 – SEC Filing

CUSIP No. M2239P109 13G

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

RA Capital Management, LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)  ¨
(b)  ¨
3. SEC Use Only
4. Citizenship or Place of Organization         Massachusetts
Number of
Owned by
Each Reporting
Person With
5. Sole Voting Power                           0 shares
6. Shared Voting Power            1,308,234 shares
7. Sole Dispositive Power                 0 shares
8. Shared Dispositive Power      1,308,234 shares

Aggregate Amount Beneficially Owned by Each Reporting Person



Check if the Aggregate Amount
in Row (9) Excludes

Certain Shares (See Instructions)


Percent of Class Represented by Amount in Row (9)



Type of Reporting Person (See Instructions)




1 The reporting person is the beneficial owner of
1,308,234 ordinary shares of the Issuer which constitute approximately 4.7% of the Issuer’s outstanding ordinary shares.
The percentage calculation assumes that there are currently 27,560,920 outstanding ordinary shares of the Issuer, based on the
Issuer’s Form 20-F as filed with the Securities and Exchange Commission (“SEC”) on March 4, 2016.


Follow Arcturus Therapeutics Ltd.
Trade (ARCT) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.